Federal Court Overturns HRSA 340B Child Site Registration Requirement
A federal district court vacated HRSA's requirement that off-site facilities (child sites) must appear on a hospital's Medicare cost report and be registered in OPAIS before purchasing drugs at 340B prices. This effectively returns pandemic-era flexibilities and may expand 340B purchasing eligibility for FQHCs with satellite locations.
Primary source
Forvis MazarsFQHC Talent. (2026, March 3). Federal Court Overturns HRSA 340B Child Site Registration Requirement. Primary source: Forvis Mazars. Retrieved June 12, 2026, from https://www.fqhctalent.com/intel/340b-child-site-registration-overturned-mar-2026
More in Risk & Compliance
Jul 5
Section 1557 Language Access Annual Notice Year 1 Anniversary — July 5, 2026 Compliance Window
Jun 9
FTCA CY2027 redeeming applications due June 26 — miss it and your FQHC has a malpractice-coverage gap
Jun 1
Two Compliance Signals for FQHCs: HRSA's FY2026 340B Manufacturer-Audit Results Go Live, and OCR's Ransomware Settlements Preview a Tougher HIPAA Security Rule
Jun 1
Eli Lilly Gives ~50 Covered Entities Five Days to Hand Over 340B Claims Data — or Lose Their Discounts